← Evidence map

ArticleLeukemia2021

Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab.

Shuntaro Ikegawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2021
2022
2023
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33597730